Complex interactions of cellular players in chronic Graft-versus-Host Disease

Front Immunol. 2023 Jun 26:14:1199422. doi: 10.3389/fimmu.2023.1199422. eCollection 2023.

Abstract

Chronic Graft-versus-Host Disease is a life-threatening inflammatory condition that affects many patients after allogeneic hematopoietic stem cell transplantation. Although we have made substantial progress in understanding disease pathogenesis and the role of specific immune cell subsets, treatment options are still limited. To date, we lack a global understanding of the interplay between the different cellular players involved, in the affected tissues and at different stages of disease development and progression. In this review we summarize our current knowledge on pathogenic and protective mechanisms elicited by the major involved immune subsets, being T cells, B cells, NK cells and antigen presenting cells, as well as the microbiome, with a special focus on intercellular communication of these cell types via extracellular vesicles as up-and-coming fields in chronic Graft-versus-Host Disease research. Lastly, we discuss the importance of understanding systemic and local aberrant cell communication during disease for defining better biomarkers and therapeutic targets, eventually enabling the design of personalized treatment schemes.

Keywords: GvHD pathogenesis; cell-cell communication; chronic graft-versus-host disease; hematopoietic stem cell transplantation; immune cell networks.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigen-Presenting Cells
  • B-Lymphocytes
  • Bronchiolitis Obliterans Syndrome*
  • Cell Communication
  • Extracellular Vesicles*
  • Humans

Grants and funding

This work was supported by COST (European Cooperation in Science and Technology). www.cost.eu - COST Action 17138 EUROGRAFT. KB-K and PŁ are also supported by a grant from the National Science Centre (Poland): 2018/31/NZ2/03065. REC is supported by the Newcastle Hospitals Charity and a Mallinckrodt Investigator Initiated Research (IIR) Award. KJS is supported by The Pathological Society of Great Britain.